Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2456-2460

  Quan, Selwyn ^a   Venter, Heidi ^a,b   Dabbs, Eric R ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF JOHANNESBURG   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GENE DISRUPTION; GENE TARGETING; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MYCOBACTERIUM SMEGMATIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL;

EID: 0030725246     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2456     Document Type: Article

References (38)

1. Abadi, F. J., P. E. Carter, P. Cash, and T. H. Pennington. 1996. Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability. Antimicrob. Agents Chemother. 40:645-651.
2. Aldovini, A., R. N. Hudson, and R. A. Young. 1993. The uraA locus and homologous recombination in Mycobacterium bovis BCG. J. Bacteriol. 175: 7282-7289.
3. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
4. Andersen, S. J., S. Quan, B. Gowan, and E. R. Dabbs. 1997. Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic. Antimicrob. Agents Chemother. 41: 218-221.
5. Balasubramanian, V., M. S. Pavelka, S. S. Bardarov, J. Martin, T. R. Weisbrod, R. A. McAdam, B. R. Bloom, and W. R. Jacobs. 1996. Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J. Bacteriol. 178:273-279.
6. Barnes, W. M., M. Bevan, and P. H. Son. 1983. Kilo-sequencing: creation of an ordered nest of asymmetric deletions across a large target sequence carried on phage M13. Methods Enzymol. 101:98-122.
7. Bibb, M. J., P. R. Findlay, and M. W. Johnson. 1985. The relationship between base composition and codon usage in bacterial genes and its use for the simple and reliable identification of protein-coding sequences. Gene 30:157-166.
8. Brown, C. M., M. E. Dalphin, P. A. Stockwell, and W. P. Tate. 1993. The translational termination signal data base. Nucleic Acids Res. 21:3119-3123.
9. Clave, D., M. Archambaud, R. M. Rouquet, P. Massip, and N. Moati. 1991. In vitro activity of twenty antibiotics against Rhodococcus equi. Pathol. Biol. 39:424-428.
10. Dabbs, E. R. 1987. Rifampicin inactivation by Rhodococcus and Mycobacterium species. FEMS Microbiol. Lett. 44:395-399.
11. Dabbs, E. R., B. Gowan, and S. J. Andersen. 1990. Nocardioform arsenic resistance plasmids and construction of Rhodococcus cloning vectors. Plasmid 23:242-247.
12. Dabbs, E. R., K. Yazawa, Y. Mikami, M. Miyaji, N. Morisaki, S. Iwasaki, and K. Furihata. 1995. Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation. Antimicrob. Agents Chemother. 39:1007-1009.
13. Dabbs, E. R., K. Yazawa, Y. Tanaka, Y. Mikami, M. Miyaji, S. J. Andersen, N. Morisaki, S. Iwasaki, O. Shida, H. Takagi, and K. Kadowaki. 1995. Rifampicin inactivation by Bacillus species. J. Antibiot. 48:815-819.
14. Dabbs, E. R., B. Gowan, S. Quan, and S. J. Andersen. 1995. Development of improved Rhodococcus plasmid vectors and their use in cloning genes of potential commercial and medical importance, p. 129-135. In Proceedings of the 9th International Symposium on Biology of Actinomycetes, Moscow, Russia.
15. Emmons, W., B. Reichwein, and D. L. Winslow. 1991. Rhodococcus equi infection in patients with AIDS: literature review and report of an unusual case. Rev. Infect. Dis. 13:91-96.
16. Grosset, J. H. 1989. Present status for chemotherapy for tuberculosis. Rev. Infect. Dis. 11:5347-5352.
17. Gough, J. A., and N. E. Murray. 1983. Sequence diversity among related genes for recognition of specific targets in DNA molecules. J. Mol. Biol. 166:1-19.
18. Guerrero, C., L. Stockman, F. Marchesi, T. Bodmer, G. D. Roberts, and A. Telenti. 1994. Evaluation of rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare. J. Antimicrob. Chemother. 33:661-663.
19. Hetherington, S. V., A. S. Watson, and C. C. Patrick. 1995. Sequence and analysis of rpoB gene of Mycobacterium smegmatis. Antimicrob. Agents Chemother. 39:2164-2166.
20. Honore, N., and S. T. Cole. 1993. Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob. Agents Chemother. 37:414-418.
21. Hui, J., N. Gordon, and R. Kajoika. 1977. Permeability barrier to rifampin in mycobacteria. Antimicrob. Agents Chemother. 11:773-779.
22. Husson, R. N., B. E. James, and R. A. Young. 1990. Gene replacement and expression of foreign DNA in mycobacteria. J. Bacteriol. 172:519-524.
23. Kesseler, M., E. R. Dabbs, B. Averhoff, and G. Gottschalk. 1996. Studies on the isopropylbenzene 2,3-dioxygenase and the 3-isopropylcatechol 2,3-dioxygenase genes encoded by the linear plasmid of Rhodococcus erythropolis BD2. Microbiology 142:3241-3251.
24. Maggi, N., C. R. Pasqualucci, R. Ballotta, and P. Sensi. 1966. Rifampicin: a new orally active rifamycin. Chemotherapy (Basel) 11:285-292.
25. 24a. Mizuguchi, Y. Personal communication.
26. Mizuguchi, Y., T. Udou, and T. Yamada. 1983. Mechanism of antibiotic resistance in Mycobacterium intracellulare. Microbiol. Immunol. 27:425-431.
27. Mizuguchi, Y., H. Taniguchi, Y. Nikaido, and T. Yamasaki. 1995. Molecular basis of rifampicin resistance in Mycobacterium tuberculosis, p. 14-15. In Symposium: Dialogues of Resistance between Clinical Bacteria and Antibiotic Producers.
28. Ohno, K., H. Koga, S. Kohno, T. Tashiro, and K. Hara. 1996. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
29. Quan, S., and E. R. Dabbs. 1993. Nocardioform arsenic resistance plasmid characterization and improved Rhodococcus cloning vectors. Plasmid 28:74-79.
30. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
31. Seto, D. 1990. An improved method for sequencing double stranded plasmid DNA from minipreps using DMSO and modified template preparation. Nucleic Acids Res. 18:5905-5906.
32. Seto, D., J. Seto, P. Deshpande, and L. Hood. 1995. DMSO resolves certain compressions and signal dropouts in fluorescent dye labeled primer-based DNA sequencing reactions. DNA Seq. 5:131-140.
33. Tanaka, Y., K. Yazawa, E. R. Dabbs, K. Nishikawa, H. Komaki, Y. Mikami, M. Miyaji, N. Morisaki, and S. Iwasaki. 1996. Different rifampicin inactivation mechanisms in Nocardia and related taxa. Microbiol. Immunol. 40:1-4.
34. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. T. Cole, M. J. Colston, L. Matter, K. Schoolfer, and T. Bodmer. 1993. Detection of rifampicin resistance mutants in Mycobacterium tuberculosis. Lancet 341:647-650.
35. Van Boxtel, R. M., R. S. Lambrecht, and M. T. Collins. 1990. Effect of colonial morphology and Tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis. Antimicrob. Agents Chemother. 34:2300-2303.
36. Yamori, S., and M. Tsukamura. 1991. Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfamethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex. Microbiol. Immunol. 35:921-926.
37. Yazawa, K., Y. Mikami, N. Maeda, M. Akao, N. Morisaki, and S. Iwasaki. 1993. Inactivation of rifampin by Nocardia brasiliensis. Antimicrob. Agents Chemother. 37:1313-1317.
38. Yazawa, K., Y. Mikami, N. Maeda, N. Morisaki, and S. Iwasaki. 1994. Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum. J. Antimicrob. Chemother. 33:1127-1135.